Terms: = Lymphoma AND PIM1, PIM, 5292, ENSG00000137193, P11309
232 results:
1. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract] [Full Text] [Related]
2. The Genetic Profile of Large B-Cell lymphomas Presenting in the Ocular Adnexa.
Vest SD; Eriksen PRG; de Groot FA; de Groen RAL; Kleij AHR; Kirkegaard MK; Kamper P; Rasmussen PK; von Buchwald C; de Nully Brown P; Kiilgaard JF; Vermaat JSP; Heegaard S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542066
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of genomic alterations in Epstein-Barr virus-positive and Epstein-Barr virus-negative diffuse large B-cell lymphoma.
Liu F; Tian S; Liu Q; Deng Y; He Q; Shi Q; Chen G; Xu X; Yuan J; Nakamura S; Karube K; Wang Z
Cancer Med; 2024 Feb; 13(4):e6995. PubMed ID: 38457199
[TBL] [Abstract] [Full Text] [Related]
4. Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy.
Zou H; Liu W; Wang X; Wang Y; Wang C; Qiu C; Liu H; Shan D; Xie T; Huang W; Sui W; Yi S; An G; Xu Y; Ma T; Wang J; Qiu L; Zou D
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38443094
[TBL] [Abstract] [Full Text] [Related]
5. The impact of MYD88 and pim1 in mature large B-cell non-Hodgkin lymphomas: Defining element of their evolution and prognosis.
Cristian M; Așchie M; Mitroi AF; Deacu M; Boșoteanu M; Bălțătescu GI; Stoica AG; Nicolau AA; Enciu M; Crețu AM; Caloian AD; Orășanu CI; Poinăreanu I
Medicine (Baltimore); 2024 Feb; 103(6):e36269. PubMed ID: 38335426
[TBL] [Abstract] [Full Text] [Related]
6. Identification and assessment of new pim2 inhibitors for treating hematologic cancers: A combined approach of energy-based virtual screening and machine learning evaluation.
Chen X; Zhao J; Chen R; Shen L; Lu J; Guo Y; Chi X; Geng S; Zhang Q; Pan Z; He X; Xu L; Shen Z; Yang H; Lei T
Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300516. PubMed ID: 38263717
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive Insights that Targeting pim for Cancer Therapy: Prospects and Obstacles.
Chen L; Mao W; Ren C; Li J; Zhang J
J Med Chem; 2024 Jan; 67(1):38-64. PubMed ID: 38164076
[TBL] [Abstract] [Full Text] [Related]
8. Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system.
Jedlowski PM; DuPont JP
J Eur Acad Dermatol Venereol; 2024 May; 38(5):937-944. PubMed ID: 38071595
[TBL] [Abstract] [Full Text] [Related]
9. The acetylation of STAT3 at K685 attenuates NPM-ALK-induced tumorigenesis.
Korai A; Lin X; Tago K; Funakoshi-Tago M
Cell Signal; 2024 Feb; 114():110985. PubMed ID: 38000524
[TBL] [Abstract] [Full Text] [Related]
10. Next-Generation Sequencing of Vitreoretinal lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.
Kwak JJ; Lee KS; Lee J; Kim YJ; Choi EY; Byeon SH; Chang WS; Kim YR; Kim JS; Shin S; Lee ST; Kim SS; Lee CS
Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):27. PubMed ID: 37975847
[TBL] [Abstract] [Full Text] [Related]
11. The genetic landscape of histologically transformed marginal zone lymphomas.
Li A; Yi H; Deng S; Ruan M; Xu P; Huo Y; Lu H; Shen X; Ouyang B; Cai M; Xu H; Wang Z; Zhang L; Zhu L; Peng Q; Gu Y; Xie J; Wang Y; Dong L; Liu Z; Wang C
Cancer; 2024 Apr; 130(8):1246-1256. PubMed ID: 37941429
[TBL] [Abstract] [Full Text] [Related]
12. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin lymphoma.
Gomez F; Fisk B; McMichael JF; Mosior M; Foltz JA; Skidmore ZL; Duncavage EJ; Miller CA; Abel H; Li YS; Russler-Germain DA; Krysiak K; Watkins MP; Ramirez CA; Schmidt A; Martins Rodrigues F; Trani L; Khanna A; Wagner JA; Fulton RS; Fronick CC; O'Laughlin MD; Schappe T; Cashen AF; Mehta-Shah N; Kahl BS; Walker J; Bartlett NL; Griffith M; Fehniger TA; Griffith OL
Cancer Res Commun; 2023 Nov; 3(11):2312-2330. PubMed ID: 37910143
[TBL] [Abstract] [Full Text] [Related]
13. KZ02 enhances the radiosensitivity of BRAF-mutated CRC in vitro and in vivo.
Guo Y; Li X; Yuan R; Ren J; Huang Y; Yu Y; Tian H
Eur J Pharmacol; 2023 Nov; 959():176060. PubMed ID: 37775019
[TBL] [Abstract] [Full Text] [Related]
14. Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL).
Kim PM; Nejati R; Lu P; Thakkar D; Mackrides N; Dupoux V; Nakhoda S; Baldwin DA; Pei J; Dave SS; Wang YL; Wasik MA
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37730436
[TBL] [Abstract] [Full Text] [Related]
15. Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
Veltmaat N; Zhong Y; de Jesus FM; Tan GW; Bult JAA; Terpstra MM; Mutsaers PGNJ; Stevens WBC; Mous R; Vermaat JSP; Chamuleau MED; Noordzij W; Verschuuren EAM; Kok K; Kluiver JL; Diepstra A; Plattel WJ; van den Berg A; Nijland M
J Hematol Oncol; 2023 Sep; 16(1):104. PubMed ID: 37705050
[TBL] [Abstract] [Full Text] [Related]
16. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of genomic alterations in primary central nervous system lymphoma.
He X; Fan X; Shan Y; Ji X; Su L; Wang Y
Medicine (Baltimore); 2023 Sep; 102(35):e34931. PubMed ID: 37657032
[TBL] [Abstract] [Full Text] [Related]
18. IGH 3'RR recombination uncovers a non-germinal center imprint and c-MYC-dependent IGH rearrangement in unmutated chronic lymphocytic leukemia.
Al Jamal I; Parquet M; Guiyedi K; Aoufouchi S; Le Guillou M; Rizzo D; Pollet J; Dupont M; Boulin M; Faumont N; Boutouil H; Jardin F; Ruminy P; El Hamel C; Lerat J; Al Hamaoui S; Makdissy N; Feuillard J; Gachard N; Peron S
Haematologica; 2024 Feb; 109(2):466-478. PubMed ID: 37496419
[TBL] [Abstract] [Full Text] [Related]
19. Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.
Kaulen LD; Denisova E; Hinz F; Hai L; Friedel D; Henegariu O; Hoffmann DC; Ito J; Kourtesakis A; Lehnert P; Doubrovinskaia S; Karschnia P; von Baumgarten L; Kessler T; Baehring JM; Brors B; Sahm F; Wick W
Acta Neuropathol; 2023 Sep; 146(3):499-514. PubMed ID: 37495858
[TBL] [Abstract] [Full Text] [Related]
20. Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various lymphoma Subtypes.
Kim JJ; Kim HM; Kim H; Kim SJ; Lee ST; Choi JR; Shin S; Hwang DY
Cancer Res Treat; 2024 Jan; 56(1):314-323. PubMed ID: 37475138
[TBL] [Abstract] [Full Text] [Related]
[Next]
